Experimental animal studies have shown that coronary occlusion is followed by myocardial
infarction and that coronary reperfusion can limit infarction size. Myocardial necrosis and the …

Optimalization of thrombolytic therapy for acute myocardial infarction can be achieved at the
site of the causal coronary lesion and at the myocardium at risk. Acute percutaneous …

Thrombolysis has become an accepted form of therapy for acute myocardial infarction. As
demonstrated in the Global Utilization of Streptokinase and t-PA for Occluded Arteries trial …

Coronary artery disease is the single leading cause of death in the United States. Occlusion
of the coronary artery was identified to be the cause of myocardial infarction almost a century …

The salvage of myocardium in the setting of acute myocardial infarction has long been a
goal of physicians involved in the care of patients with coronary artery disease …

OBJECTIVES: To compare outcomes from accelerated alteplase (recombinant tissue
plasminogen activator, t-PA) and streptokinase use in acute myocardial infarction …

Intracoronary infusion of streptokinase is associated with recanalization rates of 60 to 90%
immediately after the procedure. Mortality data in published trials are conflicting. In 125 …

Thrombotic complications of cardiovascular diseases are a main cause of death and
disability, and consequently thrombolysis could favorably influence the outcome of such life …